[Eprosartan mesylate in controlling of blood pressure in patients with ischemic stroke].

In 20 patients with ischemic stroke and moderate or severe arterial hypertension the effectiveness of eprosartan mesilat (Teveten, Solway Farma, Germany) for a period of 6 months was studied. Patients received 600 mg of eprosartan mesilat daily and in 4 cases hydrochlortyaside was also added. Monotherapy with eprosartan mesilat was effective in all patients with moderate arterial hypertension and in 43.6% in patients with severe arterial hypertension. Therapy with eprosartan mesilat was associated with significant hypotensive effect (more evident in patients with high systolic blood pressure), improvement in 24-hour blood pressure profile and quality of life, and lower probability of secondary stroke. Side effects were not observed.
AuthorsM Iu Martynov, A N Boĭko, E B Petukhov, V P Berezov, A N Maskarov, E I Gusev
JournalZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 102 Issue 4 Pg. 26-30 ( 2002) ISSN: 1997-7298 [Print] Russia (Federation)
Vernacular TitlePrimenenie éprosartana mezilata dlia kontrolia urovnia arterial'nogo davleniia u bol'nykh s ishemicheskim insul'tom.
PMID12001661 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Imidazoles
  • Thiophenes
  • eprosartan mesylate dihydrate
  • Aged
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Brain (blood supply)
  • Brain Ischemia (etiology)
  • Cerebrovascular Circulation (physiology)
  • Female
  • Humans
  • Hypertension (complications, diagnosis, prevention & control)
  • Imidazoles (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Thiophenes (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: